Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study for Identification of Predictive Immune Biomarker in Peripheral Blood for Nivolumab Therapy in NSCLC Patients

NCT03486119 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT03486119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03486119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study for Identification of Predictive Immune Biomarker in Peripheral Blood for Nivolumab Therapy in NSCLC Patients
Lead sponsor
Yonsei University
Phase
Observational
Overall status
Completed
Start date
February 5, 2018
Completion date
July 7, 2020
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non -small cell lung cancer